XOMAP FY 2014 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$19M-46.8% YoY

Gross Profit

-$11M-56.2% margin

Operating Income

-$82M-433.8% margin

Net Income

-$38M-203.0% margin

EPS (Diluted)

$-3.38

Cash Flow

Operating Cash Flow

-$78M

Free Cash Flow

-$79M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$90M

Total Liabilities

$87M

Stockholders' Equity

$3M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$35M	-46.8%
Gross Profit	-$11M	$8M	-231.1%
Operating Income	-$82M	-$58M	-40.6%
Net Income	-$38M	-$124M	+69.1%